US drug industry's guidelines on advertising too limited, say critics

US drug industry's guidelines on advertising too limited, say critics

The 15 point guidelines released by the Pharmaceutical Research and Manufacturers of America (PhRMA), which are scheduled to take effect in January 2006, propose that signatories "should spend an appropriate amount of time to educate health professionals about a new medicine or a new therapeuti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ 2005-08, Vol.331 (7514), p.420-420
1. Verfasser: Burton, Bob
Format: Artikel
Sprache:eng
Schlagworte:
Advertising
Advertising as Topic - standards
Criticism
Drug Industry - standards
Frist, Bill
Guidelines
Guidelines as Topic
News
Pharmaceutical industry
Prescription drugs
United States
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The 15 point guidelines released by the Pharmaceutical Research and Manufacturers of America (PhRMA), which are scheduled to take effect in January 2006, propose that signatories "should spend an appropriate amount of time to educate health professionals about a new medicine or a new therapeutic indication before commencing the first DTC [direct to consumer] advertizing."
ISSN:0959-8138
0959-8146
1468-5833
1756-1833
DOI:10.1136/bmj.331.7514.420-b